CHX is a pharmaceutical company introducing the only proprietary, proven and approved treatment to prevent adult dental decay.
CHX has developed and gained approval for Prevora, a clear, topical antibacterial tooth coating which is a new standard of preventive care for the older dental patient. Prevora has successfully completed all Phase III studies and is approved for a unique indication in Canada and Europe. A new drug application to the FDA is scheduled for 2014. CHX is currently testing a co-op marketing model in Southern Ontario called Partners in Prevention.